STEMI Trial Fails to Support Post-PCI Anticoagulation

The randomized RIGHT trial, testing 48 hours of post-PCI anticoagulation in STEMI patients, failed to document either benefit or increased risk.

Related Keywords

Shaoping ,Jiangxi ,China ,Belgium ,Beijing ,Chinese ,Ryan ,Pascal Vranckx ,Hartcentrum Hasselt ,Capital Medical University ,Critical Care Services ,Academic Research Consortium ,European Society Of Cardiology ,Beijing Anzhen Hospital ,European Society ,Nie Shaoping ,Bleeding Academic Research Consortium ,Cardiac Critical Care Services ,Myocardial Infarction ,Istemi ,T Segment Elevation Mi ,St Segment Elevation Myocardial Infarction ,Percutaneous Coronary Intervention ,Anticoagulation Therapy ,Anticoagulant ,Anticoagulation , ,Clinical Research ,Clinical Trials ,Linical Studies ,